Insulin pump therapy with automated insulin suspension: Toward freedom from nocturnal hypoglycemia

JAMA

Volumn 310, Issue 12, 2013, Pages 1235-1236

  Choudhary, Pratik ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

AUTOMATION; AWARENESS; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HIGH RISK PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN PUMP; INSULIN TREATMENT; NOCTURNAL HYPOGLYCEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSOR AUGMENTED INSULIN PUMP;

EID: 84884608407     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.278576     Document Type: Editorial

References (17)

1. Davis EA, Keating B, Byrne GC, et al. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care. 1997;20(1):22-25. (Pubitemid 27020036)
2. Böhme P, Bertin E, Cosson E, Chevalier N. Fear of hypoglycaemia in patients with type 1 diabetes. Diabetes Metab. 2013;39(1):63-70.
3. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-1476.
4. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33(5):1004-2081.
6. Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795-800.
7. Buckingham B, Block J, Burdick J, et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther. 2005;7(3):440-447. (Pubitemid 40847806)
8. Leelarathna L, Nodale M, Allen JM, et al. Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems. Diabetes Technol Ther. 2013;15(2):143-149.
9. Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011;13(11):1129-1134.
10. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34(9):2023-2025.
11. Ly TT, Nicholas JA, Retterath A, et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310(12):1240-1247.
12. Ly TT, Hewitt J, Davey RJ, et al. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care. 2011;34(1):50-52.
13. Choudhary P, Geddes J, Freeman JV, et al. Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia. Diabet Med. 2010;27(6):666-672.
14. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care. 2002;25(9):1499-1503. (Pubitemid 41071101)
15. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369(3):224-232.
16. Choudhary P, Ramasamy S, Gallen G, et al. Reduction in severe hypoglycaemia with the use of continuous glucose monitoring in clinical practice. Diabetic Med. 2013;30(suppl 1):398.
17. Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes. Diabetes Care. 2012;35(8):1638-1642.